Histological and ultrastructural alterations in an animal model of Peyronie's disease

British Journal of Urology

Volumn 81, Issue 3, 1998, Pages 445-452

  El Sakka, A I ^a,c   Hassan, M U ^b   Nunes, L ^b   Bhatnagar, R S ^a   Yen, T S B ^a   Lue, T F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Growth factors; Peyronie's disease; Transforming growth factor ; Tunica albuginea

Indexed keywords

COLLAGEN; CYTOKINE; HEPTAPEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELASTIC FIBER; ELASTOSIS; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; MALE; NONHUMAN; PEYRONIE DISEASE; PRIORITY JOURNAL; RAT; TIME; TRANSMISSION ELECTRON MICROSCOPY; TUNICA ALBUGINEA;

ANIMALS; COLLAGEN; DISEASE MODELS, ANIMAL; MALE; MICROSCOPY, ELECTRON; PENILE INDURATION; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031869403     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00529.x     Document Type: Article

References (38)

1. Smith BH. Peyronie's disease. Am J Clin Path 1966; 45: 670-8
2. Scardico PL, Scott WW. The use of tocopherols in the treatment of Peyronie's disease. Ann NY Amd -SYi 1949; 52: 390
3. Yudkin JS. Peyronie's disease in association with metoprolol (letter to the editor). Lancet 1977; 2: 1355
4. Van de Berg JS. Devine CJ. Horton CE et al. Mechanisms of calcification in Peyronie's disease. J Urol 1982; 127: 52-4
5. Hsu GL, Brock G. Martinez-Pinero L, von Heyden B. Lue TF. The three dimensional structure of the human tunica albuginea: anatomical and ultrastructural levels. IntJ Impot Res 1992; 4: 117-29
6. Hsu GL. Brock G, von Heyden B, Nunes L. Lue TF. Tanagho EA. The distribution of elastic fibrous elements within the human penis. Br J Urol 1994; 37: 566-71
7. Luangknot R. Rutchik S, Agarwal V. Pugulia K. Bhargava G. Melman A. Collagen alterations in the corpus cavernosum of men with sexual dysfunction. J owl 1992; 148: 467-71
8. Brock G. Hsu GL, Nunes L. von Heyden B. Lue TF. The anatomy of the tunica albuginea in the normal penis and Peyronie's disease. J Urol 1997; 157: 276-81
9. Akkus E. Carrier S. Baba K et al. Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence. Br J Urol 1997; 79: 47-53
10. Phillips CL. Tajima S. Pinnell SR. Ascorbic acid and transforming growth factor- bl increase collagen biosynthesis via different mechanisms: coordinate regulation of ProAl (I) and ProAl (III) collagens. Arch Biochem Biophys 1992; 295: 397-403
11. Durinio V. Huber BE. Jacob S. Partial down-regulation of protein kinase C reverses the growth inhibitory effect of phorbol esters on HepG2 cells. J Cell Physiol 1990; 45: 381-9
12. Terrell TG, Working PK. Chow CP. Green JD. Pathology of recombinant human transforming growth factor β-1 in rats and rabbits. Int Rev Experimen Patlwl 1993; 34: 43-67
13. Border WA. Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin luvest 1992; 90: 1-7
14. El-Sakka AI. Hassoba HM. Pillarisetty RJ. Nunes L. Dahiya R. Lue TF. Peyronie's disease is associated with an increase in transforming growth factor beta protein expression. J Urol 1997; 157 (Suppl): 361
15. Devine CJ Jr, Horton CE. Peyronie's disease. Clin Plast Surg 1988; 15:405-9
16. Van de Berg JS, Devine CJ, Horton KD et al. Peyronie's disease: an electron microscopic study. J Ural 1981; 126: 333-6
17. Sporn MB. Roberts AB. Transforming growth factor-β: recent progress and new challenges. J Cell Biol 1992; 119: 1017-21
18. Roberts AB, Sporn MB. The transforming growth factors-β. In Sporn MB, Roberts AB, eds, Handbook of Experimental Pharmacology. Vol. 95/1. Peptide Growth Factors and Their Receptors. New York: Springer-Verlag 1990: 419-47
19. Massagué J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6: 597-641
20. Moses HL, Yang EY, Pietenpol JA. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990; 63: 245-7
21. Sporn MB, Roberts AB. TGF-β: problems and prospects. CellRegul 1990; 1: 1-8
22. Assoian RK, Sporn MB. Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol 1986; 102: 1217-23
23. Wahl SM. Hunt DA, Wakefleld LM et al. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci 1987; 84: 5788-92
24. Gold LI. Lee TC, Reibman J, Cronstein R, Weissmann G. TGF-β selectively induces neutrophil chemotaxis. J Cell Biochem (Suppl) 1990; 14: 294
25. Postlethwaite AE, Keski-Oja J, Moses HL, Rang AH. Stimulation of the chemotactic migration of human flbroblasts by transforming growth factor β. J Exp Med 1987; 165: 251-6
26. Roberts AB, Sporn MB, Assoian RK et al. Transforming growth factor type β: rapid induction of flbrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 1986; 83: 4167-71
27. Kehrl JH, Wakefield LM, Roberts AB et al. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037-50
28. Ristow HJ. BSC-1 growth inhibitor/type β transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci 1986; 83: 5531-3
29. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-β. Nature 1988; 334: 260-2
30. Balza E, Borsi L, Allemanni G, Zardi L. Transforming growth factor βregulates levels of different flbronectin isoforms in normal human cultured flbroblasts. Fed Eur Biochem Soc Lett 1988; 228: 42-4
31. Wang A, Cohen DS, Palmer E, Sheppard D. Polarized regulation of flbronectin secretion and alternative splicing by transforming growth factor β. J Biol Chem 1991; 266: 15598-601
32. Ignotz RA, Massagué J. Transforming growth factor-β stimulates the expression of flbronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986:261:4337-45
33. Bassols A, Massagué J. Transforming growth factor β regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 1988; 263: 3039-45
34. Pearson CA, Pearson D, Shibahara S, Hofsteenge J, Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-β. Eur Mol Biol Organ J 1988; 7: 2977-81
35. Edwards DR, Murphy J, Reynolds J et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. Eur Mol Biol Organ J 1987; 6: 1899-904
36. Laiho M. Saksela O, Keski-Oja J. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J Biol Chem 1987; 262: 17467-74
37. Ignotz RA, Massagué J. Cell adhesion protein receptors as targets for transforming growth factor-β action. Cell 1987; 51: 189-97
38. Bosse A, Wulf M, Wiethege T, Voss B, Muller KM. Collagens and growth factors in heterotopic ossification. Pathology 1994; 15: 216-25